Yanping Xu, MD, PhD, is a postdoctoral researcher at The Ohio State University. She received her medical training in China and has extensive clinical experience in cardiovascular medicine before transitioning to translational biomedical research. Her research focuses on the molecular mechanisms underlying cardiovascular diseases and skeletal muscle regeneration. Her recent work integrates multi-omics approaches, single-cell technologies, and functional animal models to identify novel therapeutic targets for heart failure, myocardial infarction, and muscle disorders. Dr. Xu is the recipient of the American Heart Association (AHA) Postdoctoral Fellowship and has published research in peer-reviewed cardiovascular and physiology journals. She currently serves as a Guest Editor for the Special Issue Cardiovascular Disease: Pathogenesis and Treatment.